BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 16, Issue 1
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Expert Consensus
©The Author(s) 2026.
World J Transplant. Mar 18, 2026; 16(1): 114367
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.114367
Table 5 Anti-thymocyte globulin dose modification (standard dose: Body weight × 1.25 mg/day)[49]
Lab value
ATG dose
WBC2000/mm3 to 3000/mm3Dose halved
< 2000/mm3ATG stopped
Platelet< 75000/mm3 but > 50000/mm3Dose halved
< 50000/mm3ATG stopped
ATG: Anti-thymocyte globulin; WBC: White blood cell.
Full Size Table
  • Citation: Kute VB, Balwani MR, Shrimali JB, Pasari A, Kher V, Patel MP, Chafekar D, Guditi S, Das P, Siddaiah GM, Godara SM, Bhargava V, Gupta A, Ramteke V, Deshpande N, Tolani P, Prasad N, Patil RK, Mohanka R, Mahajan S, Sharma S, Banerjee S, Engineer DP, Agarwal D, Kashiv P, Lahiri A, Khullar D, Srivastava A. Induction therapy in kidney transplant recipients: A consensus statement of Indian Society of Organ Transplantation. World J Transplant 2026; 16(1): 114367
  • URL: https://www.wjgnet.com/2220-3230/full/v16/i1/114367.htm
  • DOI: https://dx.doi.org/10.5500/wjt.v16.i1.114367
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.